Please login to the form below

Not currently logged in
Email:
Password:

Thermo Fisher

This page shows the latest Thermo Fisher news and features for those working in and with pharma, biotech and healthcare.

Create Health announces relaunch under new creativity banner

Create Health announces relaunch under new creativity banner

Create Health works with brands including Thermo Fisher Scientific, ConvaTec, BD and HOYA and timed the relaunch to coincide with a virtual event headlined by TedX talker and ex-global marketer

Latest news

More from news
Approximately 2 fully matching, plus 10 partially matching documents found.

Latest Intelligence

  • AI: the smart money is on the smart thinking AI: the smart money is on the smart thinking

    Indeed, this has been evidenced recently by Thermo Fisher’s acquisition of Qiagen in May for $11.5bn.

  • A rising tide A rising tide

    This year satellite events were also held at inVentiv Health's London office, at Roche in Basel and at Thermo Fisher in Darmstadt, to which the New York ceremony was

  • Coming to an understanding Coming to an understanding

    thinking is increased,” says Dr Thomas Hein, president of EphMRA and global director customer insights and strategy immunodiagnostics at Thermo Fisher Scientific. ... Dr Hein has applied the practice at Thermo Fisher Scientific with in-house experts

  • Guiding decisions Guiding decisions

    is president of EphMRA and global director customer insights and strategy immunodiagnostics at Thermo Fisher Scientific.

  • Pharma deals during January 2015 Pharma deals during January 2015

    In a similar vein, other off the top 20 table deal activity of note was the announcement by AstraZeneca of four academic collaborations (Wellcome Trust, Innovative Genomics Institute, Thermo Fisher Scientific

More from intelligence
Approximately 0 fully matching, plus 5 partially matching documents found.

Latest appointments

  • Editas Medicine names James Mullen as chairman Editas Medicine names James Mullen as chairman

    Previously, Mullen has served as chief executive officer of Patheon, a pharmaceutical development and manufacturing services provider, until its acquisition by Thermo Fisher Scientific last year.

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
90TEN

90TEN is a global healthcare communications consultancy with a mission to make people healthier and happier through life-changing education and...

Latest intelligence

How innovating study sites can improve patient recruitment efficiency
There are so many ways that clinical trials have innovated over the last few years. There is now a larger focus on making trials more patient-centric, more virtualised, and more...
PME-MAY21-Cover
Avoiding A Series of Unfortunate Events: launch lessons from lockdown
Chris Ross takes a novel look at launch excellence through the lens of COVID-19 and explores how pharma’s launch leaders are rewriting the story...
6 reasons patients drop out of clinical trials and 6 ways to fix it
If you’ve successfully recruited patients for your clinical trial, but one by one, they begin to drop out, then this information could be for you....